CLINICAL_TRIALS
trial_result
· 2013-06-26
Clinical Trial Update: An Efficacy Study of Teriflunomide in Participants With Relapsing Multiple Sclerosis [Phase 3]
Summary
Phase 3 efficacy study results for teriflunomide in relapsing multiple sclerosis have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Multiple Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2013-06-26